Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | 177Lu-NeoB |
Trade Name | |
Synonyms | lutetium neoB|177Lu-NeoBOMB1|Lutetium 177-NeoB |
Drug Descriptions |
177Lu-NeoB is a radioconjugate comprising the radionuclide Lutetium-177 linked to the GRPR-antagonist NeoB (NeoBOMB1), which delivers radiation to GRPR-expressing tumor cells, potentially resulting in inhibition of tumor growth (PMID: 37640941, PMID: 27609789). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C158734 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
177Lu-NeoB | 177Lu-NeoB | 0 | 0 |
177Lu-NeoB + Fulvestrant + Ribociclib | 177Lu-NeoB Fulvestrant Ribociclib | 0 | 1 |